Intelligent Bio Solutions (INBS) Income from Continuing Operations (2019 - 2025)
Intelligent Bio Solutions' quarterly Income from Continuing Operations came in at 2550561.0 in Q1 2025, up 14.58% year-on-year from 2226085.11 in Q1 2024, and down 13.05% quarter-over-quarter from 2256047.0 in Q4 2024.
Intelligent Bio Solutions has reported Income from Continuing Operations for 7 years, with the latest figure at 2550561.0 in Q1 2025.
- For the quarter ending Q1 2025, Income from Continuing Operations rose 14.58% year-over-year to 2550561.0; the trailing twelve-month figure through Mar 2025 stood at 10313073.0 (changed 0.4% YoY), and the FY2024 full-year result was 10283174.0, up 18.29% from the prior year.
- Income from Continuing Operations for Q1 2025 stood at 2550561.0, down from 2256047.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 850230.0 in Q2 2021, with the low at 6352017.0 in Q1 2023.
- Average Income from Continuing Operations over 5 years is 2505932.24, with a median of 2550561.0 recorded in 2025.
- Year-over-year, Income from Continuing Operations sank 2728.5% in 2021 and jumped 57.23% in 2022.
- Tracing INBS's Income from Continuing Operations over 5 years: stood at 3463823.0 in 2021, then surged by 38.52% to 2129494.0 in 2022, then advanced by 5.13% to 2020316.0 in 2023, then slipped by 11.67% to 2256047.0 in 2024, then retreated by 13.05% to 2550561.0 in 2025.
- The last three Income from Continuing Operations figures came in at 2550561.0 (Q1 2025), 2256047.0 (Q4 2024), and 2694748.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -2.55 Mn |
| Dec 31, 2024 | -2.26 Mn |
| Sep 30, 2024 | -2.69 Mn |
| Jun 30, 2024 | -2.81 Mn |
| Mar 31, 2024 | -2.99 Mn |
| Dec 31, 2023 | -2.02 Mn |
| Sep 30, 2023 | -2.56 Mn |
| Jun 30, 2023 | -2.70 Mn |
| Mar 31, 2023 | -6.35 Mn |
| Dec 31, 2022 | -2.13 Mn |
| Sep 30, 2022 | -1.21 Mn |
| Jun 30, 2022 | -2.08 Mn |
| Mar 31, 2022 | -1.34 Mn |
| Dec 31, 2021 | -3.46 Mn |
| Sep 30, 2021 | -1.44 Mn |
| Jun 30, 2021 | -850,230.00 |
| Mar 31, 2021 | -3.14 Mn |
| Dec 31, 2020 | -1.99 Mn |
| Sep 30, 2020 | -1.08 Mn |
| Jun 30, 2020 | -463,980.00 |
| Mar 31, 2020 | -111,107.00 |
| Dec 31, 2019 | -1.85 Mn |